Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Nagai, Makiko, Re, Diane B, Nagata, Tetsuya, Chalazonitis, Alcmène, Jessell, Thomas M, Wichterle, Hynek, Przedborski, Serge·2007·Nature Neuroscience

Cited by (1,000)

Items 701–800 of 1,000

  1. Stem cell therapy for amyotrophic lateral sclerosis
    Zhijuan Mao, Suming Zhang, Hong Chen · 2015 · Cell Regeneration
  2. Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis
    Fernanda Gubert, Ana B. Decotelli, Igor Bonacossa-Pereira, Fernanda R. Figueiredo, Camila Zaverucha-do-Valle, Fernanda Freire Tovar-Moll, Luísa Hoffmann, Turán Peter Urmenyi, Marcelo F. Santiago, Rosalia Méndez‐Otero · 2016 · Stem Cell Research & Therapy
  3. Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
    Yinan Zhang, Kevin Tianmeng Zhao, Susan G. Fox, Jin-Ho Kim, Donald R. Kirsch, Robert J. Ferrante, Richard I. Morimoto, Richard B. Silverman · 2015 · Journal of Medicinal Chemistry
  4. Gene therapy for amyotrophic lateral sclerosis
    Thais Federici, Nicholas M. Boulis · 2011 · Neurobiology of Disease
  5. Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models
    Mohit Raja Jain, Weiwen Ge, Stella Elkabes, Hong Li A · 2008 · PROTEOMICS - CLINICAL APPLICATIONS
  6. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia
    Oliver H. Tam, Nikolay V. Rozhkov, Regina Shaw, Duyang Kim, Isabel Hubbard, Samantha Fennessey, Nadia Propp, Delphine Fagegaltier, Lyle W. Ostrow, Hemali P. Phatnani et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Could sirtuin activities modify ALS onset and progression?
    Tang, Bor Luen · 2017 · Cellular and Molecular Neurobiology
  8. Exploring the properties and potential of the neural extracellular matrix for next‐generation regenerative therapies
    J. Alberto Ortega, Gisele Priscila Soares de Aguiar, Palash Chandravanshi, Natacha Levy, Elisabeth Engel, Zaida Álvarez · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  9. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
    Sarah Logan, Thiago Arzua, Scott Glen Canfield, Emily R. Seminary, Samantha L. Sison, Allison D. Ebert, Xiaowen Bai · 2019 · Comprehensive physiology
  10. Endoplasmic Reticulum Interaction Supports Energy Production and Redox Homeostasis in Mitochondria Released from Astrocytes
    Jihyun Park, Eng H. Lo, Kazuhide Hayakawa · 2021 · Translational Stroke Research
  11. Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets
    Laura Ferraiuolo, Nicholas John Maragakis · 2021 · Neuroscience Letters
  12. Glial Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
    Patricia Cassina, Ernesto Miquel, Laura Martínez Palma, Adriana Cassina · 2021 · NeuroImmunoModulation
  13. Singling out motor neurons in the age of single-cell transcriptomics
    Jacob A. Blum, Aaron D. Gitler · 2022 · Trends in Genetics
  14. Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain
    Akiko Amano, Nobuo Sanjo, Wataru Araki, Yasutaka Anraku, Makoto Nakakido, Etsuro Matsubara, Takami Tomiyama, Tetsuya Nagata, Kouhei Tsumoto, Kazunori Kataoka et al. · 2023 · Journal of Nanobiotechnology
  15. Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
    Akanksha Onkar, Fatima Khan, Anshika Goenka, Ramya Lakshmi Rajendran, Crismita Dmello, Chae Moon Hong, Nida Mubin, Prakash Gangadaran, Byeong‐Cheol Ahn · 2024 · ACS Applied Materials & Interfaces
  16. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms
    Nicole Wächter, Alexander Storch, Andreas Hermann · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  17. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats
    Yan-Qin Wang, Ganlan Bian, Ya Mei Bai, Rong Yue Cao, Liang-Wei Chen · 2008 · Neurochemistry International
  18. Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
    Charlotte Veyrat‐Durebex, Philippe Corcia, Audrey Dangoumau, Frédéric Laumonnier, Éric Piver, P. H. Gordon, Christian Robert Andres, Patrick Vourc’h, Hélène Blasco · 2013 · Molecular Neurobiology
  19. Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
    Vincenzo Silani, Cinzia Calzarossa, Lidia Cova, Nicola Ticozzi · 2010 · CNS & Neurological Disorders - Drug Targets
  20. Current controversies in Niemann–Pick C1 disease: steroids or gangliosides; neurons or neurons and glia
    Robert P. Erickson · 2013 · Journal of Applied Genetics
  21. Amyotrophic Lateral Sclerosis Model Derived from Human Embryonic Stem Cells Overexpressing Mutant Superoxide Dismutase 1
    Tamaki Wada, Sravan Kumar Goparaju, Norie Tooi, Haruhisa Inoue, Ryōsuke Takahashi, Norio Nakatsuji, Kazuhiro Aiba · 2012 · Stem Cells Translational Medicine
  22. Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
    Lorelei Stoica, Miguel Sena‐Esteves · 2016 · Frontiers in Molecular Neuroscience
  23. Proteomics and Toxicity Analysis of Spinal-Cord Primary Cultures upon Hydrogen Sulfide Treatment
    Viviana Greco, Alida Spalloni, Victor Corasolla Carregari, Luisa Pieroni, Silvia Persichilli, Nicola Biagio Mercuri, Andrea Urbani, Patrizia Longone · 2018 · Antioxidants
  24. Androgen receptors in muscle fibers induce rapid loss of force but not mass: Implications for spinal bulbar muscular atrophy
    Kentaro Oki, Robert W. Wiseman, Stephen Marc Breedlove, Cynthia L. Jordan · 2013 · Muscle & Nerve
  25. 24S-hydroxycholesterol affects redox homeostasis in human glial U-87 MG cells
    Luisa Cigliano, Maria Stefania Spagnuolo, Gaetana Napolitano, Lucia Iannotta, Gianluca Fasciolo, Daniela Barone, Paola Venditti · 2019 · Molecular and Cellular Endocrinology
  26. Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
    Bradley Roberts, Frances Theunissen, Francis L. Mastaglia, Patrick Anthony Akkari, Loren L. Flynn · 2022 · International Journal of Molecular Sciences
  27. The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
    Megan Fowler, Frances Theunissen, Jillian M. Carr, Mary‐Louise Rogers · 2023 · Molecular Neurobiology
  28. mTOR Pathway – Novel Modulator of Astrocyte Activity
    Anna Latacz, John A. Russell, Ewa Anna Oclon, Joanna Zubel–Łojek, K Pierzchała · 2015 · Folia Biologica
  29. ALS-Linked P56S-VAPB Mutation Impairs the Formation of Multinuclear Myotube in C2C12 Cells
    Yukako Tokutake, Keita Yamada, Masaki Ohata, Yoshihito Obayashi, Megumi Tsuchiya, Shinichi Yonekura · 2015 · International Journal of Molecular Sciences
  30. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1 transgenic mouse model of ALS
    Yasuhiro Yoshii, Asako Otomo, Lei Pan, Masato Ohtsuka, Shinji Hadano · 2011 · Neuroscience Research
  31. Human glial progenitor engraftment and gene expression is independent of the ALS environment
    Amanda M. Haidet-Phillips, Arpitha Doreswamy, Sarah K. Gross, Xiaopei Tang, James T. Campanelli, Nicholas John Maragakis · 2014 · Experimental Neurology
  32. Quantity and Activation of Myofiber-Associated Satellite Cells in a Mouse Model of Amyotrophic Lateral Sclerosis
    Raquel Manzano, Janne M. Toivonen, Ana Cristina Calvo, Sara Oliván, P. Zaragoza, Marı́a Jesús Muñoz, Didier Montarras, Rosario Osta · 2011 · Stem Cell Reviews and Reports
  33. Increased expression of the beta3 subunit of voltage-gated Na+ channels in the spinal cord of the SOD1G93A mouse
    Michele Nutini, Alida Spalloni, Fulvio Florenzano, Ruth E. Westenbroek, Claudia Marini, William A. Catterall, Giorgio Bernardi, Patrizia Longone · 2011 · Molecular and Cellular Neuroscience
  34. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1 mutant mice
    Rachit Bakshi, Yuehang Xu, Kaly A. Mueller, Xiqun Chen, Eric J. Granucci, Sabrina Paganoni, Ghazaleh Sadri‐Vakili, Michael A. Schwarzschild · 2018 · Molecular and Cellular Neuroscience
  35. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis
    Paula Korhonen, Eveliina Pollari, Katja M. Kanninen, Ekaterina Savchenko, Šárka Lehtonen, Sara Wojciechowski, Yuriy Pomeshchik, Ludo Van Den Bosch, Gundars Goldsteins, Jari Koıstınaho et al. · 2019 · IBRO Reports
  36. The rise of astrocytes: are they guardians or troublemakers of the brain disorder?
    Hee Yeon Kim, Seungchan Kim, Asli Nur Akaydin, S S Kim, Seung Jae Hyeon, Jung-Hee Lee, Hoon Ryu · 2026 · Experimental & Molecular Medicine
  37. SOD1 G93A Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism
    Soledad Marton, Ernesto Miquel, Joaquín Acosta-Rodríguez, Santiago Fontenla, Gabriela Libisch, Patricia Cassina · 2023 · ASN NEURO
  38. The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Kangqin Yang, Yang Liu, Min Zhang · 2024 · Brain Sciences
  39. Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application
    Chen Benkler, Daniel Offen, Eldad Melamed, Lana Kupershmidt, Tamar Amit, Silvia A. Mandel, Moussa B. H. Youdim, Orly Weinreb · 2010 · The EPMA Journal
  40. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells
    Yasuo Katayama, Toshiki Inaba, Chikako Nito, Masayuki Ueda, Ken‐ichiro Katsura · 2014 · Brain Research
  41. Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C
    Manuel E. Lopez, Matthew P. Scott · 2013 · Disease Models & Mechanisms
  42. Multimodal Synchrotron Radiation Microscopy of Intact Astrocytes from the hSOD1 G93A Rat Model of Amyotrophic Lateral Sclerosis
    Tanja Dučić, Stefan Stamenković, Barry Chi Hong Lai, Pavle R. Anđjus, Vladan Lučić · 2018 · Analytical Chemistry
  43. Chronic infusion of SOD1G93A astrocyte‐secreted factors induces spinal motoneuron degeneration and neuromuscular dysfunction in healthy rats
    Uri Nimrod Ramírez-Jarquín, Fabiola Rojas, Brigitte van Zundert, Ricardo Tapia · 2017 · Journal of Cellular Physiology
  44. Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis
    Kevin H. J. Park, Inez J. Vincent · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  45. Nrf2 Regulates Basal Glutathione Production in Astrocytes
    Jiali He, Sandra J. Hewett · 2025 · International Journal of Molecular Sciences
  46. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
    Manuel José Rodríguez, Nicole Mahy · 2016 · Current Medicinal Chemistry
  47. Contributions of Drug Transporters to Blood-Brain Barriers
    Li Liu, Xiaodong Liu · 2019 · Advances in experimental medicine and biology
  48. Why should we care about astrocytes in a motor neuron disease?
    Katarina Stoklund Dittlau, Ludo Van Den Bosch · 2023 · Frontiers in Molecular Medicine
  49. Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase
    Jean‐Nicolas Audet, Genevíève Gowing, Renée Paradis, Geneviève Soucy, Jean‐Pierre Julien · 2012 · PLoS ONE
  50. Programming and reprogramming neuronal subtypes in the central nervous system
    Caroline Rouaux, Salman F Bhai, Paola Arlotta · 2012 · Developmental Neurobiology
  51. Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors
    Tamara Major, Jayanthi Menon, Gordon Auyeung, Frank Soldner, Dirk F. Hockemeyer, Rudolf Jaenisch, Viviane S. Tabar · 2011 · PLoS ONE
  52. Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures
    Gabriel N. Valbuena, Massimo Tortarolo, Caterina Bendotti, Lavinia Cantoni, Hector C. Keun · 2017 · Scientific Reports
  53. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis
    Courtney M. Clark, Rosemary M. Clark, Joshua A. Hoyle, Tracey C. Dickson · 2020 · Journal of Neurochemistry
  54. Meteorin is upregulated in reactive astrocytes and functions as a negative feedback effector in reactive gliosis
    Hye Shin Lee, SOON-HEE LEE, Jong‐Ho Cha, Ji Hae Seo, Bum Ju Ahn, Kyu-Won Kim · 2015 · Molecular Medicine Reports
  55. Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function
    Arnaud Jacquier, Sarah Bellouze, Stéphane Blanchard, Delphine Bohl, Georg Haase · 2009 · Human Molecular Genetics
  56. Inhibitory Dysfunction in Amyotrophic Lateral Sclerosis: Future Therapeutic Opportunities
    Rosemary M. Clark, Catherine A. Blizzard, Tracey C. Dickson · 2015 · Neurodegenerative Disease Management
  57. A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases
    Riccardo Cristofani, V. Crippa, M.E. Cicardi, B. Tedesco, Veronica Ferrari, Marta Chierichetti, Elena Casarotto, Margherita Piccolella, Elio Messi, M. Galbiati et al. · 2020 · Frontiers in Aging Neuroscience
  58. CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
    Cassandra N. Dennys, Florence S. Roussel, Rochelle Rodrigo, Xiaojin Zhang, Julieth A. Sierra-Delgado, Annalisa M. Hartlaub, Asya Saelim‐Ector, Will Ray, Sarah Heintzman, Ashley Fox et al. · 2022 · Glia
  59. Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity
    Winanto Ng, Shi‐Yan Ng · 2022 · Translational Neurodegeneration
  60. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology
    Ying Liu, Wenbin Deng · 2015 · Brain Research
  61. The non-cell-autonomous component of ALS: new in vitro models and future challenges
    Laura Ferraiuolo · 2014 · Biochemical Society Transactions
  62. Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes
    Milena M. Milosevic, Matjaž Stenovec, Marko Kreft, Vladimir Petrušić, Zorica Stević, Saša Trkov, Pavle R. Anđjus, Robert Zorec · 2013 · Cell Calcium
  63. Scolopendra subspinipes mutilans attenuates neuroinflammation in symptomatic hSOD1G93Amice
    Mudan Cai, Sun‐Mi Choi, Bong Keun Song, Ilhong Son, Sungchul Kim, Eun Jin Yang · 2013 · Journal of Neuroinflammation
  64. In vivo imaging reveals rapid morphological reactions of astrocytes towards focal lesions in an ALS mouse model
    Payam Dibaj, Heinz Steffens, Jana Zschüntzsch, Frank Kirchhoff, Eike Dieter Schomburg, Clemens Neusch · 2011 · Neuroscience Letters
  65. Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
    Sonja Mendritzki, Saskia Schmidt, Teresa Sczepan, Xin‐Ran Zhu, Daniel Segelcke, Hermann Lübbert · 2010 · Parkinson s Disease
  66. Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies
    Akemi Ido, Hidenao Fukuyama, Makoto Urushitani · 2011 · International Journal of Molecular Sciences
  67. In Vivo Astrocytic Ca 2+ Signaling In Health and Brain Disorders
    Shinghua Ding · 2013 · Future Neurology
  68. Astrocytes in Motor Neuron Diseases
    Chiara F. Valori, Giulia Guidotti, Liliana Brambilla, Daniela Rossi · 2019 · Advances in experimental medicine and biology
  69. Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy
    Elena Seranova, Adina Maria Palhegyi, Surbhi Verma, Simona Dimova, Rachel Lasry, Moriyah Naama, Congxin Sun, Timothy Geoffrey Barrett, Tatiana Rosado Rosenstock, Dhiraj Kumar et al. · 2020 · Journal of Molecular Biology
  70. Astrocytes in Amyotrophic Lateral Sclerosis
    Sandra Henriques Vaz, Sara Pinto, Ana Maria Sebastião, Dora Maria Tuna Oliveira Brites · 2021 · Exon Publications eBooks
  71. Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1G93A rat
    Stefan Stamenković, Tanja Dučić, Vera Stamenković, Alexander Kranz, Pavle R. Anđjus · 2017 · Neuroscience
  72. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease
    Yiota A Christou, H. D. M. Moore, Pamela J. Shaw, Peter N. Monk · 2007 · Neuropathology and Applied Neurobiology
  73. Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model
    Megan Baird, Shibi B. Likhite, Tatyana A. Vetter, Joseph R. Caporale, Holly B Girard, Florence S. Roussel, Abigail E Howard, Maura K. Schwartz, Addison R. Reed, Abuzar Kaleem et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  74. Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases
    Christine L. Péladeau, Jagdeep K. Sandhu · 2021 · International Journal of Molecular Sciences
  75. SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
    Valeria Valsecchi, Francesco Errico, Valentina Bassareo, Carmen Marino, Tommaso Nuzzo, Paola Brancaccio, Giusy Laudati, Antonella Casamassa, Manuela Grimaldi, Adele D’Amico et al. · 2023 · Communications Biology
  76. Discovery of a Small Molecule that Enhances Astrocytogenesis by Activation of STAT3, SMAD1/5/8, and ERK1/2 via Induction of Cytokines in Neural Stem Cells
    Ha‐Rim Lee, Farhanullah, JiSoo Lee, Rahul Jajoo, Sun-Young Kong, Jae-Yeon Shin, Jae‐Ouk Kim, Jeewoo Lee, Jeewoo Lee, Hyun‐Jung Kim · 2015 · ACS Chemical Neuroscience
  77. An in vitro model for studying CNS white matter: functional properties and experimental approaches
    Silvia Bijland, Gemma Thomson, Matthew Euston, Kyriakos Michail, Katja Thümmler, Steve Mücklisch, Colin L. Crawford, Susan Carol Barnett, Marκ McLaughlin, Thomas James Anderson et al. · 2019 · F1000Research
  78. The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?
    Natalia Salvadores, Felipe A. Court · 2020 · Expert Opinion on Therapeutic Targets
  79. Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis
    Julianne Aebischer, Nathalie Bernard‐Marissal, Brigitte Pettmann, Cédric Raoul · 2013 · Journal of Neurodegenerative Diseases
  80. ALS Model Glia Can Mediate Toxicity to Motor Neurons Derived from Human Embryonic Stem Cells
    Eva Hedlund, Ole Isacson A · 2008 · Cell stem cell
  81. A Review of Glutamate Receptors II: Pathophysiology and Pathology
    Colin G. Rousseaux · 2008 · Journal of Toxicologic Pathology
  82. Stem cells in amyotrophic lateral sclerosis: state of the art
    Letizia Mazzini, Alessandro Vercelli, Ivana Ferrero, Katia Mareschi, Marina Boido, Serena Servo, Gaia Donata Oggioni, Lucia Testa, Francesco Monaco, Franca Fagioli · 2009 · Expert Opinion on Biological Therapy
  83. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy – a perspective on cell biological mechanisms
    Bor Luen Tang · 2017 · Reviews in the Neurosciences
  84. Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
    Stefania Schiavone, Luigia Trabace · 2018 · Molecules
  85. A perspective on stem cell modeling of amyotrophic lateral sclerosis
    A. Sophie de Boer, Kevin C. Eggan · 2015 · Cell Cycle
  86. Are cytoskeleton changes observed in astrocytes functionally linked to aging?
    Cristopher Villablanca, René L. Vidal, Christian Enrique González-Billault · 2023 · Brain Research Bulletin
  87. Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis
    Chunchu Deng, Hong Chen · 2023 · Neurobiology of Disease
  88. Rosiglitazone regulates astrocyte polarization and neuroinflammation in a PPAR-γ dependent manner after experimental traumatic brain injury
    Xu Ren, Yun-Fei Li, Tian-Wei Pei, Hao-Sheng Wang, Yu‐Hai Wang, Tao Chen · 2024 · Brain Research Bulletin
  89. Lanthanum chloride promotes mitochondrial apoptotic pathway in primary cultured rat astrocytes
    Jinghua Yang, Qiufang Liu, Ming Qi, Shuai Lü, Shengwen Wu, Qi Xi, Yuan Cai · 2011 · Environmental Toxicology
  90. Induced Pluripotent Stem Cells and Human Disease
    Alan Colman · 2008 · Cell stem cell
  91. SAGE Analysis of Genes Differentially Expressed in Presymptomatic TgSOD1G93A Transgenic Mice Identified Cellular Processes Involved in Early Stage of ALS Pathology
    Michel Guipponi, Qiao‐Xin Li, Lavinia Hyde, Tim Beißbarth, Gordon K. Smyth, Colin Louis Masters, Hamish S. Scott · 2009 · Journal of Molecular Neuroscience
  92. Spinal muscular atrophy: Factors that modulate motor neurone vulnerability
    Wen-Yo Tu, Julie E. Simpson, J. Robin Highley, Paul Roy Heath · 2017 · Neurobiology of Disease
  93. Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading
    Vanessa X. Tan, Benjamin Lassus, Chai K. Lim, Philippe Tixador, Josquin Courte, Alban Bessede, Gilles J. Guillemin, Jean‐Michel Peyrin · 2017 · Neurotoxicity Research
  94. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis
    Tomomi Shijo, Hitoshi Warita, Naoki Suzuki, Kensuke Ikeda, Shio Mitsuzawa, Tetsuya Akiyama, Hiroya Ono, Ayumi Nishiyama, Rumiko Izumi, Yasuo Kitajima et al. · 2018 · Experimental Neurology
  95. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury
    Sarah Schram, Donald Chuang, Greg Schmidt, Hristo Piponov, Cory W. Helder, James M. Kerns, Mark H. Gonzalez, Fei Song, Jeffrey A. Loeb · 2018 · Neurobiology of Disease
  96. Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
    Jelena Ban, Cynthia Sámano, Miranda Mladinić, Ivana Munitić · 2019 · Croatian Medical Journal
  97. Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies
    Beatrice Nefussy, Vivian E. Drory · 2010 · The EPMA Journal
  98. ALS-linked SOD1 in glial cells enhances ß-N-Methylamino L-Alanine (BMAA)-induced toxicity in Drosophila
    Rafique Islam, Emily L. Kumimoto, Hong Bao, Bing Zhang · 2012 · F1000Research
  99. Increased Il-8 Levels in the Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis
    Tiziana Mennini, Laura Giordano, Manuela Mengozzi, Pietro Ghezzi, R. Tonelli, Renato Mantegazza, Vincenzo Silani, Massimo Corbo, Christian Lunetta, Ettore Beghi · 2009 · European Journal of Inflammation
  100. Heterogeneity in motoneuron disease
    Diether Lambrechts, Wim Robberecht, Peter Carmeliet · 2007 · Trends in Neurosciences